KC PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
KC PHARMA
Largest movements
- Receivables within one year +€159,989
up €159,989 (+52.7%), from €303,760 to €463,749
of which Trade receivables: +€137,269
- Receivables after one year -€25,000
down €25,000 (-6.3%), from €400,000 to €375,000
- Deferred charges and accrued income +€11,609
up €11,609 (+162.5%), from €7,145 to €18,754
- Cash -€10,047
down €10,047 (-45.7%), from €21,980 to €11,932
mainly Receivables within one year (-€159,989) and Deferred charges and accrued income (-€11,609)
- Reserves +€112,245
up €112,245 (+19.1%), from €587,285 to €699,530
- Tax, wage and social debts +€31,800
up €31,800 (+145.9%), from €21,792 to €53,592
of which Taxes: +€34,050
- Other debts -€9,040
down €9,040 (-10.4%), from €87,105 to €78,065
- Gross operating margin +€128,694
up €128,694 (+428.3%), from €30,046 to €158,741
- Taxes +€41,052
up €41,052 (+518.7%), from €7,914 to €48,966
- Other operating charges -€6,078
down €6,078 (-87.2%), from €6,968 to €890
- Financial charges -€3,471
down €3,471 (-46.2%), from €7,512 to €4,042
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €732,885 | €873,296 | +€140,411 | +19.2% |
| Fixed assets | 21/28 | - | €3,861 | +€3,861 | |
| Tangible fixed assets | 22/27 | - | €3,861 | +€3,861 | |
| Plant, machinery and equipment | 23 | - | €2,785 | +€2,785 | |
| Furniture and vehicles | 24 | - | €1,076 | +€1,076 | |
| Current assets | 29/58 | €732,885 | €869,435 | +€136,550 | +18.6% |
| Amounts receivable after more than one year | 29 | €400,000 | €375,000 | -€25,000 | -6.3% |
| Other amounts receivable | 291 | €400,000 | €375,000 | -€25,000 | -6.3% |
| Amounts receivable within one year | 40/41 | €303,760 | €463,749 | +€159,989 | +52.7% |
| Trade receivables | 40 | €7,260 | €144,529 | +€137,269 | +1890.8% |
| Other amounts receivable | 41 | €296,500 | €319,220 | +€22,720 | +7.7% |
| Cash at bank and in hand | 54/58 | €21,980 | €11,932 | -€10,047 | -45.7% |
| Deferred charges and accrued income | 490/1 | €7,145 | €18,754 | +€11,609 | +162.5% |
| Total equity and liabilities | 10/49 | €732,885 | €873,296 | +€140,411 | +19.2% |
| Equity | 10/15 | €623,785 | €736,030 | +€112,245 | +18.0% |
| Contributions | 10/11 | €36,500 | €36,500 | = | 0.0% |
| Reserves | 13 | €587,285 | €699,530 | +€112,245 | +19.1% |
| Distributable reserves | 133 | €587,285 | €699,530 | +€112,245 | +19.1% |
| Profit (loss) carried forward | 14 | - | €0 | = | |
| Amounts payable | 17/49 | €109,099 | €137,266 | +€28,166 | +25.8% |
| Amounts payable within one year | 42/48 | €109,099 | €137,266 | +€28,166 | +25.8% |
| Trade debts | 44 | €202 | €129 | -€73 | -36.3% |
| Suppliers | 440/4 | €202 | €129 | -€73 | -36.3% |
| Advances received on contracts in progress | 46 | - | €5,480 | +€5,480 | |
| Taxes, remuneration and social security | 45 | €21,792 | €53,592 | +€31,800 | +145.9% |
| Taxes | 450/3 | €19,542 | €53,592 | +€34,050 | +174.2% |
| Remuneration and social security | 454/9 | €2,250 | €0 | -€2,250 | -100.0% |
| Other amounts payable | 47/48 | €87,105 | €78,065 | -€9,040 | -10.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €863 | +€863 | |
| Other operating charges | 640/8 | €6,968 | €890 | -€6,078 | -87.2% |
| Gross operating margin | 9900 | €30,046 | €158,741 | +€128,694 | +428.3% |
| Operating profit (loss) | 9901 | €23,078 | €156,987 | +€133,909 | +580.2% |
| Financial income | 75/76B | €12,375 | €11,625 | -€750 | -6.1% |
| Recurring financial income | 75 | €12,375 | €11,625 | -€750 | -6.1% |
| Financial charges | 65/66B | €7,512 | €4,042 | -€3,471 | -46.2% |
| Recurring financial charges | 65 | €7,512 | €4,042 | -€3,471 | -46.2% |
| Profit (loss) for the period before taxes | 9903 | €27,941 | €164,571 | +€136,630 | +489.0% |
| Income taxes | 67/77 | €7,914 | €48,966 | +€41,052 | +518.7% |
| Profit (loss) for the period | 9904 | €20,026 | €115,605 | +€95,579 | +477.3% |
| Profit (loss) for the period to be appropriated | 9905 | €20,026 | €115,605 | +€95,579 | +477.3% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.